Publications by authors named "Peter Cohen"

Claim this Profile
M
Multipeptide stimulated PBMCs generate T/T for adoptive cell therapy in multiple myeloma.
Trupti Vardam-Kaur, Latha B Pathangey, Daniel J McCormick, P Leif Bergsagel, Peter A Cohen

Oncotarget· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide.
Nitin T Supekar, Vani Lakshminarayanan, Chantelle J Capicciotti, Anju Sirohiwal, Cathy S Madsen, Peter A Cohen

Chembiochem· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of condom lubricants on pre & post-coital vaginal swabs using AccuTOF-DART.
Gloria Proni, Peter Cohen, Lesley-Ann Huggins, Nasri Nesnas

Forensic Sci Int· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.
Yana G Najjar, Patricia Rayman, Xuefei Jia, Paul G Pavicic, Brian I Rini, Peter Cohen

Clin Cancer Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment.
Aliyah M Weinstein, Lu Chen, Emily A Brzana, Prashanti R Patil, Jennifer L Taylor, Peter A Cohen

Oncoimmunology· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.
Latha B Pathangey, Dustin B McCurry, Sandra J Gendler, Ana L Dominguez, Jessica E Gorman, Peter A Cohen

Oncotarget· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy can induce weight normalization of morbidly obese mice despite undiminished ingestion of high fat diet.
Cheryl E Myers, Dominique B Hoelzinger, Tiffany N Truong, Lindsey A Chew, Arpita Myles, Peter A Cohen

Oncotarget· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sticking to (first) principles: quantum molecular dynamics and Bayesian probabilistic methods to simulate aquatic pollutant absorption spectra.
Kasidet Trerayapiwat, Nathan Ricke, Peter Cohen, Alex Poblete, Holly Rudel

Environ Sci Process Impacts· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice.
Vani Lakshminarayanan, Nitin T Supekar, Jie Wei, Dustin B McCurry, Amylou C Dueck, Peter A Cohen

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.
Soraya Zorro Manrique, Ana L Dominguez, Noweeda Mirza, Christopher D Spencer, Judy M Bradley, Peter A Cohen

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337).
Gregory N Dietsch, Tressa D Randall, Raphael Gottardo, Donald W Northfelt, Ramesh K Ramanathan, Peter A Cohen

Clin Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide.
Pamela Thompson, Vani Lakshminarayanan, Nitin T Supekar, Judy M Bradley, Peter A Cohen

Chem Commun (Camb)· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benchmarks regarding multimodal peripheral nerve blocks for postoperative analgesia: observations regarding combined perineural midazolam-clonidine-buprenorphine-dexamethasone.
Brian A Williams, James W Ibinson, Michael P Mangione, Rick L Scanlan, Peter Z Cohen

Pain Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research priorities regarding multimodal peripheral nerve blocks for postoperative analgesia and anesthesia based on hospital quality data extracted from over 1,300 cases (2011-2014).
Brian A Williams, James W Ibinson, Michael P Mangione, Robert T Modrak, Elizabeth J Tonarelli, Peter Z Cohen

Pain Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of adaptive immunity by IL9 can be disrupted to achieve rapid T-cell sensitization and rejection of progressive tumor challenges.
Dominique B Hoelzinger, Ana Lucia Dominguez, Peter A Cohen, Sandra J Gendler

Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose-finding study of the novel Toll-like receptor 8 agonist VTX-2337 in adult subjects with advanced solid tumors or lymphoma.
Donald W Northfelt, Ramesh K Ramanathan, Peter A Cohen, Daniel D Von Hoff, Glen J Weiss

Clin Cancer Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist.
Abu-Baker M Abdel-Aal, Vani Lakshminarayanan, Pamela Thompson, Nitin Supekar, Judy M Bradley, Peter A Cohen

Chembiochem· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.
Thinle Chodon, Begoña Comin-Anduix, Bartosz Chmielowski, Richard C Koya, Zhongqi Wu, Peter A Cohen

Clin Cancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy.
Ritika Jaini, Patricia Rayman, Peter A Cohen, James H Finke, Vincent K Tuohy

Int J Cancer· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics.
James H Finke, Pat A Rayman, Jennifer S Ko, Judy M Bradley, Sandra J Gendler, Peter A Cohen

Cancer J· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of hematopoietic MUC1 during experimental colitis increases tumor-promoting myeloid-derived suppressor cells.
Tze Wei Poh, Cathy S Madsen, Jessica E Gorman, Ronald J Marler, Jonathan A Leighton, Peter A Cohen

Clin Cancer Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of exercise on heart-rate response to mental stress in teenagers.
Alex Costin, Nathaniel Costin, Peter Cohen, Carson Eisenach, Francis Marchlinski

Eur J Prev Cardiol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17.
Christopher Paustian, Patricia Taylor, Terrence Johnson, Min Xu, Nancy Ramirez, Peter A Cohen

PLoS One· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.
Lisa A Kottschade, Vera J Suman, Domingo G Perez, Robert R McWilliams, Judith S Kaur, Peter A Cohen

Cancer· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.
Peter A Cohen, Jennifer S Ko, Walter J Storkus, Christopher D Spencer, Judy M Bradley

Immunol Invest· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis